Expert Review of Clinical Pharmacology [ISSN 1751-2433]; [e-ISSN 1751-2441] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on all aspects of clinical safety, tolerability, efficacy and therapeutic applications. Letters to the Editor should discuss articles previously published in the journal.

The journal also covers toxicity issues, adverse reactions, pharmacoeconomics, and societal issues. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore, the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.

Please note that the journal does not publish preclinical or Phase I-II studies, unless there is a clear indication for translational medicine. Each article is structured to incorporate the author's own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.

Expert Review of Clinical Pharmacology aims to address the needs of clinical and pharmaceutical researchers, drug development specialists, physicians, and other specialists and players who are actively meeting such challenges in modern biomedical practice.

The Editors welcome novel research in the following key areas:

    ADME studies and PK/PD modelling
    Novel clinical trial design and conduct
    Toxicity and carcinogenesis
    Adverse effects/reactions, drug–drug and drug–disease interactions
    Pharmacogenetics, genomics and the incorporation of new biomarkers in drug development and clinical practice
    Pharmacoepidemiology, risk management and pharmacovigilance
    Pharmacotherapy in specific groups of people, such as children, women, the immunocompromised, and different ethnicities
    Impact on quality of life and pharmacoeconomic issues
    Regulation of drug development and marketing
    Epidemiology and biostatistics

The journal welcomes:

    Reviews
    Original research
    Editorials
    Drug profiles
    Meta-analyses
    Letters to the Editor

The journal operates a double-anonymized peer review policy.

Comprehensive coverage in each review article is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results.

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Clinical Pharmacology, part of the Expert Collection brand.

Editor in Chief 

Kaitin K, Tufts University, USA
 
Associate Editors 

Jahangir A, Mayo Clinic, MN, USA 

Postma M, Groningen Univeristy, The Netherlands 

Stingl JC, University of Ulm, Germany 

Van Den Anker J, GWU School of Medicine and Health Sciences 

Wang X, Fudan University, China
 
Editorial Advisory Panel

Alderman CP, Repatriation Gen. Hosp., Australia 

Bednarczyk E, SUNY Buffalo, NY, USA 

Cheung BMY, University of Hong Kong, China 

Cohen J, Tufts University, USA 

Dreisbach AW, Tulane University, USA 

Hay J, Univ. of Southern California, USA 

Herings R, PHARMO Institute, The Netherlands 

Hoffman P, University of Colorado, USA 

Huang S-M, CDER, FDA, USA 

Issa A, University of Houston, USA 

Khurana V, Insys Therapeutics Inc., AZ, USA 

Kamal MA, King Abdulaziz University, Jeddah, Saudi Arabia 

Kalluri HV, AbbVie Inc, North Chicago, IL, USA 

Kashyap V, Shire Pharmaceuticals, USA 

Levy HB, HbL PharmaConsulting, MO, USA 

Ma Q, SUNY Buffalo, NY, USA 

Mangoni AA, Flinders Medical Centre, Australia 

Mentzer D, Paul Ehrlich Institute, Germany 

Niemi M, Helsinki Univ. Central Hospital, Finland 

Ohashi K, Oita University. Oita, Japan 

Olech E, Oklahoma Medical Research, OK, USA 

Patsalos P, Institute of Neurology, UK 

Slaughter R, Wayne State University, USA 

Sridharan K, Arabian Gulf University, Bahrain 

Sultana J, University of Messina, Italy 

Viswanath O, Creighton University School of Medicine, USA and University of Arizona College of Medicine-Phoenix, USA 

Waldman SA, Thomas Jefferson University, PA, USA 

Waring S, York Hospital, UK